Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 5
1993 3
1994 4
1995 4
1996 8
1997 2
1998 5
1999 3
2000 6
2001 6
2002 4
2004 6
2005 6
2006 7
2007 13
2008 10
2009 9
2010 8
2011 7
2012 10
2013 5
2014 15
2015 15
2016 14
2017 16
2018 8
2019 9
2020 8
2021 14
2022 6
2023 5
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

224 results

Results by year

Filters applied: . Clear all
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Dupuis-Girod S, Rivière S, Lavigne C, Fargeton AE, Gilbert-Dussardier B, Grobost V, Leguy-Seguin V, Maillard H, Mohamed S, Decullier E, Roux A, Bernard L, Saurin JC, Saroul N, Faure F, Cartier C, Altwegg R, Laccourreye L, Oberti F, Beaudoin M, Dhelens C, Desvignes C, Azzopardi N, Paintaud G, Hermann R, Chinet T. Dupuis-Girod S, et al. Among authors: paintaud g. J Intern Med. 2023 Dec;294(6):761-774. doi: 10.1111/joim.13714. Epub 2023 Aug 23. J Intern Med. 2023. PMID: 37592715 Clinical Trial.
Recherche translationnelle dans les pathologies immuno-inflammatoires : quels défis, quels progrès attendre, pour quelles innovations thérapeutiques ?
Joubert JM, Gottenberg JE, Paintaud G; et les membres de la table ronde N° 2 de Giens XXIX; Augendre-Ferrante B, Cans C, Cellier D, Chevalier MP, Diaz I, Filipecki J, Kahn JE, Le Men J, Mulleman D, Urbain R, Vasmant D. Joubert JM, et al. Among authors: paintaud g. Therapie. 2014 Jul-Aug;69(4):291-6. doi: 10.2515/therapie/2014049. Therapie. 2014. PMID: 27393224 French. No abstract available.
[Pharmacokinetics (PK) of mAbs].
Paintaud G. Paintaud G. Med Sci (Paris). 2009 Dec;25(12):1057-62. doi: 10.1051/medsci/200925121057. Med Sci (Paris). 2009. PMID: 20035679 Free article. Review. French.
A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases.
Angeli E, Paris J, Le Tilly O, Desvignes C, Gapihan G, Boquet D, Pamoukdjian F, Hamdan D, Rigal M, Poirier F, Lutomski D, Azibani F, Mebazaa A, Herbet A, Mabondzo A, Falgarone G, Janin A, Paintaud G, Bousquet G. Angeli E, et al. Among authors: paintaud g. Exp Hematol Oncol. 2024 Apr 15;13(1):41. doi: 10.1186/s40164-024-00513-7. Exp Hematol Oncol. 2024. PMID: 38622749 Free PMC article.
The efficiency concept in pharmacodynamics.
Alván G, Paintaud G, Wakelkamp M. Alván G, et al. Among authors: paintaud g. Clin Pharmacokinet. 1999 May;36(5):375-89. doi: 10.2165/00003088-199936050-00005. Clin Pharmacokinet. 1999. PMID: 10384860 Review.
224 results